Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes
Clinical trial NCT02824003 · COMPLETED
Trial details
- NCT number
- NCT02824003
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-12-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.